<DOC>
	<DOCNO>NCT01948115</DOCNO>
	<brief_summary>The variety breech presentation term 3-4 % birth . Our study aim ass value use equimolar mixture oxygen nitrous oxide . Indeed , patient algic relaxed , success rate seem important . It 's single blind prospective randomize control study , compare success rate ECV equimolar mixture oxygen nitrous oxide placebo ( medical air ) . We need include 150 patient ( 75 arm ) , period 2 year . After ECV , give patient satisfaction questionnaire . We compare success rate ECV primary outcome .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Equimolar Mixture Oxygen Nitrous Oxide External Cephalic Version ( ECV )</brief_title>
	<detailed_description />
	<mesh_term>Breech Presentation</mesh_term>
	<mesh_term>Nitrous Oxide</mesh_term>
	<criteria>age ≥ 18 year pregnancy term ( ≥36 week ) singleton foetus breech transverse presentation acceptance ECV signature inform consent contraindication ECV : placenta praevia , obstacle praevia , multiple pregnancy , foetal death , foetal heart rhythm disorder , lack amniotic fluid , HIVpositive patient contraindication equimolar mixture oxygen nitrous oxide : patient require pure oxygen ventilation , disorder consciousness impede cooperation patient , pneumothorax , pulmonary embolism , ocular surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Breech presentation</keyword>
	<keyword>equimolar mixture oxygen nitrous oxide</keyword>
	<keyword>external cephalic version</keyword>
</DOC>